ClinicalTrials.govpublic full text
Patients With Primary Biliary Cholangitis(PBC)
primary biliary cholangitis, liver fibrosis, cirrhosis, liver, blood sugar; high, elafibranor, seladelpar, peroxisome proliferator-activated receptor agonists(ppar), inflammatory markers, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853525
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.